<DOC>
	<DOCNO>NCT00397475</DOCNO>
	<brief_summary>The purpose study determine effect colecalciferol substitution dialysis patient bone metabolism immune system</brief_summary>
	<brief_title>Evaluation Colecalciferol Substitution Dialysis Patients</brief_title>
	<detailed_description />
	<mesh_term>Renal Insufficiency</mesh_term>
	<mesh_term>Hyperparathyroidism</mesh_term>
	<mesh_term>Renal Insufficiency , Chronic</mesh_term>
	<mesh_term>Hyperparathyroidism , Secondary</mesh_term>
	<mesh_term>Cholecalciferol</mesh_term>
	<criteria>1 . Serum 25OHVit.Dlevels &lt; 60 ng/ml 2 . Age &gt; 18 year 3. dialysis treatment &gt; 3 Months 4. sign write informed consent 5 . SerumCalciumlevels &lt; 2,6 mmol/l within last 4 week 6 . SerumPhosphatelevels &lt; 7,0 mg/dl within last 4 week 7 . Ca x PProduct &lt; 75 mg2/dl2 within last 4 week 1 . Serum 25OHVit.Dlevels &gt; 60 ng/ml 2. concommitant participation another interventional trial 3. psychiatric disorder prevent valid informed consent 4 . Hyperphosphatemia ( &gt; 7,0 mg/dl ) within last 4 week 5 . Hypercalcemia ( &gt; 2,6 mmol/l ) within last 4 week 6 . Ca x PProduct &gt; 75 mg2/dl2 within last 4 week 7. pregnancy lactation 8. know malignancy 9. liver disease , define 2fold upper limit ASAT , ALATlevels 10 . PTH level &lt; 50 pg/ml 11. current clinically relevant infection treat antibiotic therapy raise hsCRP level 12 . Chronic viral Infectious disease ( e.g . HIV , Hepatitis B C ) 13 . Immunosuppressant Medication 14. know hematologic disorder , renal anemia 15. age 18 year 16. know anaphylactic reaction study medication ingredient study drug preparation 17. renal calculus 18 . Pseudohypoparathyroidism 19 . Medication include cardiac glycoside 20 . Sarkoidosis</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>May 2015</verification_date>
</DOC>